| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Neoplasms | 37 | 2025 | 1614 | 4.830 |
Why?
|
| Smoking | 20 | 2023 | 1028 | 2.790 |
Why?
|
| Genome-Wide Association Study | 23 | 2023 | 1630 | 2.160 |
Why?
|
| Genetic Predisposition to Disease | 31 | 2023 | 3050 | 1.940 |
Why?
|
| Scleroderma, Systemic | 12 | 2019 | 117 | 1.920 |
Why?
|
| Polymorphism, Single Nucleotide | 28 | 2023 | 2573 | 1.600 |
Why?
|
| Early Detection of Cancer | 4 | 2025 | 333 | 1.410 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 7 | 2025 | 339 | 1.250 |
Why?
|
| Codon, Nonsense | 3 | 2022 | 130 | 0.960 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2025 | 2030 | 0.700 |
Why?
|
| Genome, Human | 10 | 2020 | 1248 | 0.680 |
Why?
|
| Genetic Variation | 6 | 2020 | 1462 | 0.670 |
Why?
|
| Models, Biological | 3 | 2011 | 1438 | 0.660 |
Why?
|
| Neoplasm Proteins | 4 | 2018 | 666 | 0.660 |
Why?
|
| Tobacco Smoke Pollution | 3 | 2011 | 76 | 0.630 |
Why?
|
| Volatile Organic Compounds | 1 | 2017 | 9 | 0.590 |
Why?
|
| DNA Repair | 3 | 2012 | 583 | 0.580 |
Why?
|
| Breath Tests | 1 | 2017 | 179 | 0.570 |
Why?
|
| Models, Statistical | 7 | 2019 | 447 | 0.560 |
Why?
|
| Case-Control Studies | 19 | 2020 | 3229 | 0.550 |
Why?
|
| Quantitative Trait Loci | 6 | 2022 | 266 | 0.540 |
Why?
|
| Genomic Imprinting | 3 | 2007 | 123 | 0.530 |
Why?
|
| Mutation, Missense | 10 | 2024 | 826 | 0.520 |
Why?
|
| Neoplasms | 8 | 2020 | 2753 | 0.510 |
Why?
|
| Diet | 2 | 2013 | 1106 | 0.490 |
Why?
|
| Humans | 75 | 2025 | 122287 | 0.480 |
Why?
|
| Models, Genetic | 4 | 2008 | 747 | 0.460 |
Why?
|
| Genetic Linkage | 4 | 2007 | 449 | 0.460 |
Why?
|
| Gene Frequency | 7 | 2022 | 703 | 0.460 |
Why?
|
| Carcinogenesis | 1 | 2017 | 332 | 0.460 |
Why?
|
| Risk Factors | 23 | 2023 | 9901 | 0.450 |
Why?
|
| Alleles | 6 | 2020 | 1579 | 0.440 |
Why?
|
| Multivariate Analysis | 4 | 2022 | 1407 | 0.430 |
Why?
|
| Sex Factors | 4 | 2011 | 1238 | 0.430 |
Why?
|
| Introns | 1 | 2014 | 303 | 0.430 |
Why?
|
| Betaine | 1 | 2013 | 22 | 0.430 |
Why?
|
| Choline | 1 | 2013 | 54 | 0.420 |
Why?
|
| Neoplasm Staging | 4 | 2025 | 1227 | 0.420 |
Why?
|
| Selection, Genetic | 3 | 2024 | 150 | 0.410 |
Why?
|
| Middle Aged | 27 | 2020 | 25636 | 0.400 |
Why?
|
| Male | 40 | 2025 | 59515 | 0.390 |
Why?
|
| Computer Simulation | 6 | 2025 | 606 | 0.390 |
Why?
|
| Models, Theoretical | 1 | 2014 | 351 | 0.390 |
Why?
|
| Logistic Models | 8 | 2022 | 1772 | 0.370 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2023 | 1890 | 0.370 |
Why?
|
| Aged | 21 | 2020 | 18783 | 0.370 |
Why?
|
| Odds Ratio | 6 | 2022 | 1234 | 0.360 |
Why?
|
| Evolution, Molecular | 1 | 2014 | 669 | 0.360 |
Why?
|
| Receptors, Nicotinic | 1 | 2011 | 154 | 0.350 |
Why?
|
| Female | 36 | 2025 | 64880 | 0.350 |
Why?
|
| SEER Program | 2 | 2025 | 193 | 0.330 |
Why?
|
| Genetic Loci | 4 | 2016 | 334 | 0.320 |
Why?
|
| Biological Evolution | 4 | 2015 | 221 | 0.310 |
Why?
|
| Research Design | 1 | 2011 | 646 | 0.290 |
Why?
|
| Body Size | 1 | 2007 | 51 | 0.280 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2007 | 73 | 0.280 |
Why?
|
| Prostatic Neoplasms | 5 | 2017 | 1516 | 0.280 |
Why?
|
| Feeding Behavior | 1 | 2011 | 676 | 0.260 |
Why?
|
| Genes, Neoplasm | 2 | 2019 | 79 | 0.260 |
Why?
|
| Data Interpretation, Statistical | 2 | 2005 | 202 | 0.250 |
Why?
|
| Melanoma | 2 | 2023 | 835 | 0.240 |
Why?
|
| Skin Neoplasms | 2 | 2023 | 802 | 0.240 |
Why?
|
| Oncogenes | 2 | 2022 | 172 | 0.230 |
Why?
|
| Gene Expression Profiling | 5 | 2019 | 1674 | 0.230 |
Why?
|
| Family | 1 | 2007 | 565 | 0.230 |
Why?
|
| Genetic Association Studies | 2 | 2022 | 738 | 0.230 |
Why?
|
| Receptors, Interleukin-12 | 2 | 2014 | 9 | 0.220 |
Why?
|
| Neoplasm Metastasis | 2 | 2025 | 650 | 0.220 |
Why?
|
| Interferon Regulatory Factors | 2 | 2014 | 40 | 0.220 |
Why?
|
| Survival Analysis | 2 | 2025 | 1468 | 0.220 |
Why?
|
| Mutation | 4 | 2024 | 5734 | 0.210 |
Why?
|
| RNA Splicing | 3 | 2014 | 223 | 0.210 |
Why?
|
| Software | 1 | 2007 | 670 | 0.200 |
Why?
|
| Nucleotides | 1 | 2022 | 91 | 0.200 |
Why?
|
| Cohort Studies | 8 | 2023 | 4642 | 0.200 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2014 | 168 | 0.200 |
Why?
|
| Adult | 15 | 2023 | 28728 | 0.200 |
Why?
|
| Germ-Line Mutation | 2 | 2020 | 312 | 0.190 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2024 | 646 | 0.190 |
Why?
|
| Prognosis | 5 | 2023 | 4488 | 0.190 |
Why?
|
| Frameshift Mutation | 2 | 2019 | 172 | 0.190 |
Why?
|
| Exons | 3 | 2014 | 793 | 0.190 |
Why?
|
| Conserved Sequence | 1 | 2022 | 291 | 0.190 |
Why?
|
| Venous Thrombosis | 1 | 2023 | 182 | 0.190 |
Why?
|
| Aged, 80 and over | 9 | 2020 | 6289 | 0.180 |
Why?
|
| Tumor Burden | 2 | 2012 | 231 | 0.180 |
Why?
|
| Reproducibility of Results | 4 | 2022 | 2797 | 0.180 |
Why?
|
| Venous Thromboembolism | 1 | 2023 | 161 | 0.180 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2020 | 90 | 0.170 |
Why?
|
| Glioblastoma | 1 | 2023 | 327 | 0.170 |
Why?
|
| Obesity | 2 | 2007 | 2083 | 0.160 |
Why?
|
| Genotype | 8 | 2018 | 2525 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2019 | 112 | 0.160 |
Why?
|
| Body Mass Index | 2 | 2005 | 1463 | 0.150 |
Why?
|
| Telomerase | 1 | 2019 | 165 | 0.150 |
Why?
|
| Age Factors | 4 | 2011 | 2777 | 0.150 |
Why?
|
| Octanes | 1 | 2017 | 1 | 0.150 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2017 | 77 | 0.150 |
Why?
|
| DNA-Binding Proteins | 5 | 2022 | 2029 | 0.150 |
Why?
|
| Furans | 1 | 2017 | 27 | 0.150 |
Why?
|
| Computational Biology | 3 | 2015 | 789 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2018 | 159 | 0.150 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2017 | 17 | 0.140 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2020 | 1000 | 0.140 |
Why?
|
| Risk | 3 | 2020 | 744 | 0.140 |
Why?
|
| Genomics | 3 | 2014 | 1458 | 0.140 |
Why?
|
| Breast Neoplasms | 2 | 2019 | 2480 | 0.130 |
Why?
|
| Idiopathic Interstitial Pneumonias | 1 | 2016 | 8 | 0.130 |
Why?
|
| CpG Islands | 4 | 2023 | 321 | 0.130 |
Why?
|
| Surveys and Questionnaires | 4 | 2020 | 3626 | 0.130 |
Why?
|
| Rhinitis, Allergic, Seasonal | 2 | 2006 | 24 | 0.130 |
Why?
|
| Age of Onset | 3 | 2012 | 576 | 0.130 |
Why?
|
| Pedigree | 3 | 2020 | 1533 | 0.130 |
Why?
|
| Blood | 1 | 2015 | 105 | 0.130 |
Why?
|
| Linkage Disequilibrium | 2 | 2014 | 306 | 0.120 |
Why?
|
| Adenocarcinoma | 2 | 2020 | 1001 | 0.120 |
Why?
|
| beta Karyopherins | 1 | 2014 | 12 | 0.120 |
Why?
|
| Colonic Neoplasms | 1 | 2017 | 247 | 0.120 |
Why?
|
| Genes, p53 | 2 | 2005 | 215 | 0.120 |
Why?
|
| Likelihood Functions | 2 | 2005 | 106 | 0.110 |
Why?
|
| HLA Antigens | 2 | 2014 | 240 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2014 | 83 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2014 | 83 | 0.110 |
Why?
|
| Environmental Exposure | 1 | 2015 | 217 | 0.110 |
Why?
|
| Lung | 2 | 2023 | 1476 | 0.110 |
Why?
|
| rhoB GTP-Binding Protein | 1 | 2012 | 1 | 0.100 |
Why?
|
| Biomarkers, Tumor | 3 | 2024 | 1424 | 0.100 |
Why?
|
| Europe | 4 | 2019 | 369 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 16 | 2 | 2003 | 150 | 0.100 |
Why?
|
| Food, Organic | 1 | 2011 | 3 | 0.100 |
Why?
|
| Cocarcinogenesis | 1 | 2011 | 23 | 0.100 |
Why?
|
| Autoantibodies | 2 | 2011 | 418 | 0.100 |
Why?
|
| Genetic Markers | 2 | 2011 | 594 | 0.100 |
Why?
|
| Diet, Fat-Restricted | 1 | 2011 | 39 | 0.100 |
Why?
|
| Selection Bias | 1 | 2011 | 19 | 0.100 |
Why?
|
| Membrane Proteins | 1 | 2019 | 1520 | 0.090 |
Why?
|
| Registries | 3 | 2012 | 1367 | 0.090 |
Why?
|
| Eligibility Determination | 1 | 2011 | 39 | 0.090 |
Why?
|
| Vitamin A | 1 | 2011 | 59 | 0.090 |
Why?
|
| Carotenoids | 1 | 2011 | 75 | 0.090 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2013 | 546 | 0.090 |
Why?
|
| Phenotype | 5 | 2012 | 4150 | 0.090 |
Why?
|
| CD3 Complex | 1 | 2010 | 84 | 0.090 |
Why?
|
| Interviews as Topic | 1 | 2011 | 367 | 0.090 |
Why?
|
| Fruit | 1 | 2011 | 216 | 0.090 |
Why?
|
| Genotyping Techniques | 2 | 2020 | 100 | 0.080 |
Why?
|
| Forecasting | 1 | 2011 | 355 | 0.080 |
Why?
|
| Vegetables | 1 | 2011 | 257 | 0.080 |
Why?
|
| Texas | 3 | 2013 | 3528 | 0.080 |
Why?
|
| Databases, Nucleic Acid | 2 | 2008 | 69 | 0.080 |
Why?
|
| Disease | 1 | 2010 | 128 | 0.080 |
Why?
|
| DNA Mutational Analysis | 1 | 2011 | 792 | 0.080 |
Why?
|
| Energy Intake | 1 | 2011 | 450 | 0.080 |
Why?
|
| Nuclear Proteins | 2 | 2013 | 1277 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 1008 | 0.080 |
Why?
|
| Asthma | 2 | 2006 | 743 | 0.080 |
Why?
|
| Motor Activity | 1 | 2011 | 507 | 0.080 |
Why?
|
| Disease Progression | 1 | 2014 | 1990 | 0.070 |
Why?
|
| Confidence Intervals | 1 | 2008 | 277 | 0.070 |
Why?
|
| DNA Breaks | 1 | 2007 | 26 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2008 | 421 | 0.070 |
Why?
|
| Mutagens | 1 | 2007 | 84 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 1107 | 0.070 |
Why?
|
| Organ Specificity | 2 | 2019 | 427 | 0.070 |
Why?
|
| Proteins | 1 | 2012 | 1043 | 0.070 |
Why?
|
| DNA Methylation | 2 | 2023 | 991 | 0.070 |
Why?
|
| Age Distribution | 1 | 2007 | 400 | 0.070 |
Why?
|
| Dust | 1 | 2006 | 20 | 0.070 |
Why?
|
| Genetics, Population | 2 | 2008 | 184 | 0.070 |
Why?
|
| Epidemiologic Studies | 1 | 2006 | 40 | 0.070 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2014 | 557 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 2 | 2023 | 1354 | 0.060 |
Why?
|
| Regression Analysis | 1 | 2007 | 755 | 0.060 |
Why?
|
| Cell Growth Processes | 1 | 2005 | 63 | 0.060 |
Why?
|
| Radiography, Thoracic | 1 | 2005 | 155 | 0.060 |
Why?
|
| Inflammation | 1 | 2011 | 1392 | 0.060 |
Why?
|
| Regulatory Sequences, Ribonucleic Acid | 1 | 2003 | 16 | 0.060 |
Why?
|
| Lung Diseases | 1 | 2007 | 384 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2003 | 32 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2012 | 2080 | 0.050 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2004 | 297 | 0.050 |
Why?
|
| Body Constitution | 1 | 2002 | 31 | 0.050 |
Why?
|
| Minisatellite Repeats | 1 | 2002 | 43 | 0.050 |
Why?
|
| Sample Size | 1 | 2002 | 79 | 0.050 |
Why?
|
| Monte Carlo Method | 1 | 2003 | 89 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2002 | 111 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2009 | 3307 | 0.050 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2002 | 102 | 0.050 |
Why?
|
| Constriction, Pathologic | 1 | 2023 | 237 | 0.050 |
Why?
|
| Early Diagnosis | 1 | 2003 | 178 | 0.050 |
Why?
|
| Multifactorial Inheritance | 1 | 2002 | 137 | 0.050 |
Why?
|
| Haplotypes | 2 | 2014 | 510 | 0.050 |
Why?
|
| Siblings | 1 | 2002 | 191 | 0.050 |
Why?
|
| Silent Mutation | 1 | 2020 | 3 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2002 | 368 | 0.040 |
Why?
|
| Jews | 1 | 2020 | 31 | 0.040 |
Why?
|
| Chromosome Aberrations | 1 | 2023 | 617 | 0.040 |
Why?
|
| Open Reading Frames | 2 | 2014 | 211 | 0.040 |
Why?
|
| Biomarkers | 2 | 2023 | 2933 | 0.040 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2019 | 31 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 2020 | 204 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2023 | 479 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 548 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 666 | 0.040 |
Why?
|
| Child | 3 | 2018 | 24058 | 0.040 |
Why?
|
| Mucins | 1 | 2019 | 74 | 0.040 |
Why?
|
| Algorithms | 3 | 2012 | 1575 | 0.040 |
Why?
|
| Mutation Rate | 1 | 2018 | 65 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2018 | 47 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2009 | 5962 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2022 | 565 | 0.040 |
Why?
|
| Loss of Function Mutation | 1 | 2019 | 139 | 0.040 |
Why?
|
| Heterozygote | 1 | 2020 | 675 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2020 | 463 | 0.040 |
Why?
|
| Gene-Environment Interaction | 1 | 2018 | 118 | 0.040 |
Why?
|
| Linear Models | 1 | 2019 | 657 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 353 | 0.030 |
Why?
|
| Mass Screening | 2 | 2012 | 778 | 0.030 |
Why?
|
| Young Adult | 2 | 2020 | 8759 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2011 | 12041 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2018 | 13775 | 0.030 |
Why?
|
| Carrier Proteins | 2 | 2014 | 1015 | 0.030 |
Why?
|
| Interleukin-12 Subunit p35 | 1 | 2014 | 6 | 0.030 |
Why?
|
| Autophagy-Related Protein 5 | 1 | 2014 | 12 | 0.030 |
Why?
|
| Microchip Analytical Procedures | 1 | 2014 | 6 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2012 | 15849 | 0.030 |
Why?
|
| Endodeoxyribonucleases | 1 | 2014 | 47 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2012 | 2817 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2014 | 265 | 0.030 |
Why?
|
| Co-Repressor Proteins | 1 | 2013 | 37 | 0.030 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2014 | 116 | 0.030 |
Why?
|
| Adolescent | 2 | 2018 | 18934 | 0.030 |
Why?
|
| Life Style | 1 | 2015 | 394 | 0.030 |
Why?
|
| United States | 3 | 2012 | 10487 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2014 | 241 | 0.030 |
Why?
|
| Calibration | 1 | 2012 | 82 | 0.030 |
Why?
|
| Vital Capacity | 1 | 2012 | 75 | 0.020 |
Why?
|
| Autoimmune Diseases | 1 | 2014 | 248 | 0.020 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2011 | 20 | 0.020 |
Why?
|
| Airway Remodeling | 1 | 2011 | 20 | 0.020 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2011 | 32 | 0.020 |
Why?
|
| Activin Receptors, Type I | 1 | 2011 | 33 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2012 | 284 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2013 | 469 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 2534 | 0.020 |
Why?
|
| Mortality | 1 | 2012 | 221 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2002 | 1822 | 0.020 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2012 | 147 | 0.020 |
Why?
|
| Genes, Overlapping | 1 | 2008 | 7 | 0.020 |
Why?
|
| 5' Untranslated Regions | 1 | 2008 | 59 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2008 | 166 | 0.020 |
Why?
|
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 1 | 2007 | 34 | 0.020 |
Why?
|
| Survival Rate | 1 | 2012 | 1997 | 0.020 |
Why?
|
| Comorbidity | 1 | 2012 | 1490 | 0.020 |
Why?
|
| Bleomycin | 1 | 2007 | 150 | 0.020 |
Why?
|
| Family Health | 1 | 2007 | 258 | 0.020 |
Why?
|
| Mice | 1 | 2023 | 17548 | 0.020 |
Why?
|
| Bone Neoplasms | 1 | 2010 | 428 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2018 | 8096 | 0.020 |
Why?
|
| Lod Score | 1 | 2005 | 120 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2005 | 50 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2005 | 65 | 0.020 |
Why?
|
| Incidence | 1 | 2012 | 3017 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2005 | 92 | 0.010 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2003 | 37 | 0.010 |
Why?
|
| MutL Protein Homolog 1 | 1 | 2003 | 54 | 0.010 |
Why?
|
| Infant | 1 | 2018 | 12301 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2008 | 1703 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 5013 | 0.010 |
Why?
|
| Animals | 1 | 2023 | 33723 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2005 | 446 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2003 | 523 | 0.010 |
Why?
|